MDGL logo

Madrigal Pharmaceuticals (MDGL) Selling, General & Administrative Expenses

Annual SGA

$108.15 M
+$60.02 M+124.70%

December 31, 2023


Summary


Performance

MDGL SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherMDGLexpensesmetrics:

Quarterly SGA

$107.58 M
+$2.14 M+2.03%

September 30, 2024


Summary


Performance

MDGL Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherMDGLexpensesmetrics:

TTM SGA

-$6.20 B
-$518.67 M-9.13%

September 30, 2024


Summary


Performance

MDGL TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherMDGLexpensesmetrics:

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

MDGL Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+124.7%+2.0%-2480.8%
3 y3 years+394.6%+2.0%-2480.8%
5 y5 years+607.2%+2.0%-2480.8%

MDGL Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+189.8%at high+1014.0%-170.9%at low
5 y5-yearat high+394.6%at high+2236.3%-729.7%at low
alltimeall timeat high>+9999.0%at high>+9999.0%-4732.1%at low

Madrigal Pharmaceuticals Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sep 2024
-
$107.58 M(+2.0%)
$340.37 M(+30.7%)
Jun 2024
-
$105.45 M(+30.5%)
$260.37 M(+50.7%)
Mar 2024
-
$80.80 M(+73.6%)
$172.76 M(+59.8%)
Dec 2023
$108.15 M(+124.7%)
$46.54 M(+68.7%)
$108.15 M(+42.0%)
Sep 2023
-
$27.58 M(+54.6%)
$76.17 M(+25.4%)
Jun 2023
-
$17.84 M(+10.3%)
$60.73 M(+11.1%)
Mar 2023
-
$16.18 M(+11.2%)
$54.65 M(+13.6%)
Dec 2022
$48.13 M(+29.0%)
$14.56 M(+19.9%)
$48.13 M(+6.3%)
Sep 2022
-
$12.14 M(+3.1%)
$45.28 M(+9.3%)
Jun 2022
-
$11.77 M(+21.9%)
$41.43 M(+4.2%)
Mar 2022
-
$9.66 M(-17.5%)
$39.77 M(+6.6%)
Dec 2021
$37.32 M(+70.7%)
$11.71 M(+41.3%)
$37.32 M(+17.6%)
Sep 2021
-
$8.29 M(-18.0%)
$31.73 M(+9.7%)
Jun 2021
-
$10.11 M(+40.2%)
$28.94 M(+18.3%)
Mar 2021
-
$7.21 M(+17.7%)
$24.47 M(+11.9%)
Dec 2020
$21.86 M(-3.5%)
$6.13 M(+11.5%)
$21.86 M(+5.2%)
Sep 2020
-
$5.49 M(-2.6%)
$20.78 M(+3.7%)
Jun 2020
-
$5.64 M(+22.5%)
$20.04 M(-6.8%)
Mar 2020
-
$4.61 M(-8.7%)
$21.51 M(-5.0%)
Dec 2019
$22.65 M(+48.1%)
$5.04 M(+6.2%)
$22.65 M(-2.3%)
Sep 2019
-
$4.75 M(-33.2%)
$23.19 M(-1.6%)
Jun 2019
-
$7.11 M(+23.7%)
$23.56 M(+22.9%)
Mar 2019
-
$5.75 M(+2.9%)
$19.17 M(+25.3%)
Dec 2018
$15.29 M(+99.3%)
$5.58 M(+9.0%)
$15.29 M(+26.3%)
Sep 2018
-
$5.12 M(+88.5%)
$12.11 M(+35.4%)
Jun 2018
-
$2.72 M(+45.2%)
$8.94 M(+13.9%)
Mar 2018
-
$1.87 M(-22.0%)
$7.85 M(+2.3%)
Dec 2017
$7.67 M(-17.4%)
$2.40 M(+22.7%)
$7.67 M(+2.2%)
Sep 2017
-
$1.96 M(+20.5%)
$7.50 M(-36.6%)
Jun 2017
-
$1.62 M(-4.2%)
$11.84 M(+10.0%)
Mar 2017
-
$1.70 M(-24.1%)
$10.76 M(+15.9%)
Dec 2016
$9.29 M(+1052.9%)
$2.23 M(-64.5%)
$9.29 M(+29.0%)
Sep 2016
-
$6.29 M(+1040.7%)
$7.20 M(+545.7%)
Jun 2016
-
$551.00 K(+148.2%)
$1.12 M(-69.8%)
Mar 2016
-
$222.00 K(+53.0%)
$3.69 M(-51.6%)
Dec 2015
$805.80 K(-94.9%)
$145.10 K(-26.5%)
$7.62 M(-35.0%)
Sep 2015
-
$197.40 K(-93.7%)
$11.72 M(-20.6%)
Jun 2015
-
$3.13 M(-24.7%)
$14.76 M(+1.3%)
Mar 2015
-
$4.15 M(-2.1%)
$14.57 M(-7.5%)
DateAnnualQuarterlyTTM
Dec 2014
$15.75 M(+0.3%)
$4.24 M(+30.9%)
$15.75 M(+5.2%)
Sep 2014
-
$3.24 M(+10.2%)
$14.97 M(-5.8%)
Jun 2014
-
$2.94 M(-44.8%)
$15.90 M(-7.3%)
Mar 2014
-
$5.32 M(+53.7%)
$17.14 M(+9.2%)
Dec 2013
$15.70 M(+34.5%)
$3.46 M(-17.0%)
$15.70 M(+0.7%)
Sep 2013
-
$4.17 M(-0.4%)
$15.59 M(+9.7%)
Jun 2013
-
$4.19 M(+8.0%)
$14.21 M(+10.1%)
Mar 2013
-
$3.88 M(+15.7%)
$12.91 M(+10.6%)
Dec 2012
$11.68 M(+1.1%)
$3.35 M(+19.9%)
$11.68 M(+4.9%)
Sep 2012
-
$2.80 M(-3.0%)
$11.13 M(-2.9%)
Jun 2012
-
$2.88 M(+8.9%)
$11.46 M(-0.6%)
Mar 2012
-
$2.65 M(-5.6%)
$11.53 M(-0.2%)
Dec 2011
$11.55 M(+0.9%)
$2.80 M(-10.5%)
$11.55 M(-2.1%)
Sep 2011
-
$3.13 M(+6.3%)
$11.81 M(+4.8%)
Jun 2011
-
$2.95 M(+10.2%)
$11.27 M(+2.1%)
Mar 2011
-
$2.67 M(-12.5%)
$11.04 M(-3.6%)
Dec 2010
$11.45 M(-9.5%)
$3.06 M(+17.9%)
$11.45 M(+5.8%)
Sep 2010
-
$2.59 M(-4.6%)
$10.82 M(-4.9%)
Jun 2010
-
$2.72 M(-12.0%)
$11.38 M(-2.5%)
Mar 2010
-
$3.09 M(+27.2%)
$11.67 M(-7.8%)
Dec 2009
$12.65 M(-14.2%)
$2.43 M(-22.9%)
$12.65 M(-7.6%)
Sep 2009
-
$3.15 M(+4.8%)
$13.69 M(-3.6%)
Jun 2009
-
$3.00 M(-26.2%)
$14.21 M(-6.4%)
Mar 2009
-
$4.07 M(+17.3%)
$15.18 M(+3.0%)
Dec 2008
$14.74 M(-1.3%)
$3.47 M(-5.3%)
$14.74 M(-1.9%)
Sep 2008
-
$3.67 M(-7.8%)
$15.02 M(-1.2%)
Jun 2008
-
$3.97 M(+9.4%)
$15.21 M(+0.8%)
Mar 2008
-
$3.63 M(-3.2%)
$15.09 M(+1.1%)
Dec 2007
$14.93 M(+72.7%)
$3.75 M(-2.6%)
$14.93 M(+9.0%)
Sep 2007
-
$3.85 M(-0.0%)
$13.69 M(+15.5%)
Jun 2007
-
$3.85 M(+11.1%)
$11.86 M(+48.2%)
Mar 2007
-
$3.47 M(+37.7%)
$8.00 M(+76.5%)
Dec 2006
$8.65 M(-23.3%)
$2.52 M(+24.9%)
$4.53 M(+124.9%)
Sep 2006
-
$2.02 M(-11.6%)
$2.02 M(-11.6%)
Dec 2005
$11.28 M(+52.8%)
-
-
Mar 2005
-
$2.28 M
$2.28 M
Dec 2004
$7.38 M(+40.3%)
-
-
Dec 2003
$5.26 M(+4142.7%)
-
-
Dec 2001
$124.00 K
-
-

FAQ

  • What is Madrigal Pharmaceuticals annual SGA?
  • What is the all time high annual SGA for Madrigal Pharmaceuticals?
  • What is Madrigal Pharmaceuticals annual SGA year-on-year change?
  • What is Madrigal Pharmaceuticals quarterly SGA?
  • What is the all time high quarterly SGA for Madrigal Pharmaceuticals?
  • What is Madrigal Pharmaceuticals quarterly SGA year-on-year change?
  • What is Madrigal Pharmaceuticals TTM SGA?
  • What is the all time high TTM SGA for Madrigal Pharmaceuticals?
  • What is Madrigal Pharmaceuticals TTM SGA year-on-year change?

What is Madrigal Pharmaceuticals annual SGA?

The current annual SGA of MDGL is $108.15 M

What is the all time high annual SGA for Madrigal Pharmaceuticals?

Madrigal Pharmaceuticals all-time high annual SGA is $108.15 M

What is Madrigal Pharmaceuticals annual SGA year-on-year change?

Over the past year, MDGL annual SGA has changed by +$60.02 M (+124.70%)

What is Madrigal Pharmaceuticals quarterly SGA?

The current quarterly SGA of MDGL is $107.58 M

What is the all time high quarterly SGA for Madrigal Pharmaceuticals?

Madrigal Pharmaceuticals all-time high quarterly SGA is $107.58 M

What is Madrigal Pharmaceuticals quarterly SGA year-on-year change?

Over the past year, MDGL quarterly SGA has changed by +$2.14 M (+2.03%)

What is Madrigal Pharmaceuticals TTM SGA?

The current TTM SGA of MDGL is -$6.20 B

What is the all time high TTM SGA for Madrigal Pharmaceuticals?

Madrigal Pharmaceuticals all-time high TTM SGA is -$128.28 M

What is Madrigal Pharmaceuticals TTM SGA year-on-year change?

Over the past year, MDGL TTM SGA has changed by -$6.46 B (-2480.75%)